Key statistics
As of last trade Clarity Pharmaceuticals Ltd (CLRPF:PKC) traded at 4.75, -25.76% below its 52-week high of 6.40, set on Sep 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.00 |
---|---|
High | 5.00 |
Low | 4.75 |
Bid | -- |
Offer | -- |
Previous close | 5.05 |
Average volume | 4.28k |
---|---|
Shares outstanding | 320.21m |
Free float | 239.16m |
P/E (TTM) | -- |
Market cap | 2.39bn AUD |
EPS (TTM) | -0.1541 AUD |
Data delayed at least 15 minutes, as of Nov 13 2024 14:30 GMT.
More ▼
Press releases
- Copper-67 SAR-bisPSMA updates
- Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer
- SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort
- Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA